The antibody treatment could compete with Sanofi’s Dupixent and Eli Lilly’s Ebgylss, while offering the potential for less ...

Intermittent treatment with pimecrolimus over 1 year significantly reverses corticosteroid-induced skin atrophy and ...

Apogee Therapeutics (NASDAQ:APGE) stock drops despite mid-stage trial success for APG777 in treating atopic dermatitis. Read ...

Apogee Therapeutics shares soared in premarket trading Monday after the company said it received positive trial data for its atopic dermatitis treatment. Shares traded 36% higher ahead of the morning ...

Spongiotic dermatitis describes skin inflammation that causes swelling, redness, and itching. It's most often associated with ...

Perioral dermatitis is a common skin condition that can cause bumpy, red skin. Here, expert derms share how to get rid of it, ...

A focused update to AAD’s adult AD guidelines recommends tapinarof, roflumilast, lebrikizumab, and nemolizumab based on ...

Arcutis is financially strong, with over 30 months of cash runway. The atopic dermatitis market is large and shifting away ...

When somebody's coming in that has a known diagnosis of atopic dermatitis or eczema and things are really revved up still, if ...

This new study identifies key contributors to mental health decline in individuals with atopic dermatitis, highlighting the ...

Spongiotic dermatitis is a term that refers to a specific type of skin inflammation. It affects the top layer of the skin (the epidermis), leading to fluid buildup and symptoms such as scaling ...

In this video, Robert J. Smith, MD, discusses the many treatment options available to patients with atopic dermatitis.